share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K：諾和諾德-股票回購計劃
美股SEC公告 ·  08/19 09:22

Moomoo AI 已提取核心訊息

Novo Nordisk A/S, a leading global healthcare company, has reported on the progress of its share repurchase program. The program, which began on February 6, 2024, aims to buy back shares worth up to DKK 20 billion over a 12-month period. As part of this initiative, a specific share repurchase plan was initiated on August 7, 2024, targeting the repurchase of B shares for an amount up to DKK 2.4 billion by November 4, 2024. Since the last announcement on August 12, 2024, Novo Nordisk has acquired 335,187 B shares at an average price of DKK 879.32, amounting to a total transaction value of DKK 298,612,988. These transactions are separate from the company's incentive programs, which resulted in a net transfer of 14,129 B shares from August 12 to August 16, 2024. Novo Nordisk now holds 12,730,944 B shares as treasury shares, representing 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has reported on the progress of its share repurchase program. The program, which began on February 6, 2024, aims to buy back shares worth up to DKK 20 billion over a 12-month period. As part of this initiative, a specific share repurchase plan was initiated on August 7, 2024, targeting the repurchase of B shares for an amount up to DKK 2.4 billion by November 4, 2024. Since the last announcement on August 12, 2024, Novo Nordisk has acquired 335,187 B shares at an average price of DKK 879.32, amounting to a total transaction value of DKK 298,612,988. These transactions are separate from the company's incentive programs, which resulted in a net transfer of 14,129 B shares from August 12 to August 16, 2024. Novo Nordisk now holds 12,730,944 B shares as treasury shares, representing 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
全球領先的醫療保健公司諾和諾德曾宣佈了其股票回購計劃的進展情況。該計劃於2024年2月6日啓動，旨在在12個月內回購價值高達200億丹麥克朗的股票。作爲該計劃的一部分，特定的股票回購計劃於2024年8月7日啓動，旨在在2024年11月4日之前，以高達24億丹麥克朗的金額回購B股。自2024年8月12日上次公告以來，諾和諾德已以平均每股879.32丹麥克朗的價格，收購了3351870億股，總交易金額爲298,612,988丹麥克朗。這些交易是與該公司的激勵計劃分開的，該計劃在2024年8月12日至8月16日期間，淨轉移了141290億股。諾和諾德現持有127309440億股作爲庫存股，佔股本的0.3％。該公司的股票在納斯達克哥本哈根交易，並且在紐約證券交易所上市的美國存託憑證也同樣如此。
全球領先的醫療保健公司諾和諾德曾宣佈了其股票回購計劃的進展情況。該計劃於2024年2月6日啓動，旨在在12個月內回購價值高達200億丹麥克朗的股票。作爲該計劃的一部分，特定的股票回購計劃於2024年8月7日啓動，旨在在2024年11月4日之前，以高達24億丹麥克朗的金額回購B股。自2024年8月12日上次公告以來，諾和諾德已以平均每股879.32丹麥克朗的價格，收購了3351870億股，總交易金額爲298,612,988丹麥克朗。這些交易是與該公司的激勵計劃分開的，該計劃在2024年8月12日至8月16日期間，淨轉移了141290億股。諾和諾德現持有127309440億股作爲庫存股，佔股本的0.3％。該公司的股票在納斯達克哥本哈根交易，並且在紐約證券交易所上市的美國存託憑證也同樣如此。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間